Healthcare

Host Response

Biomeme's ultra-sensitive, highly accurate molecular detection technology makes host response an actionable and accessible diagnostic tool in the race against antibiotic misuse and Antimicrobial Resistance (AMR).

Novel Diagnostic

Revolutionizing Healthcare with Host Response

Our novel Host Response Test (HR-B/V) is the key to providing unparalleled sensitivity and reliability for providers differentiating between bacterial and viral infections.

Download Resource

Lab professional working with Biomeme technology

Capabilities

Body Language Decoded

Our versatile platform is built to be the end-to-end molecular detection solution to help providers with their antibiotic stewardship strategies and quality initiatives.

Compact Design

Performs like an advanced lab — no special equipment required. Designed for point-of-care use.

Precision

Simultaneously measure a multiplexed panel of mRNA targets to detect the host gene response signature with lab-grade accuracy.

Actionable Results

Administered prior to prescribing antibiotics — results in under an hour.

Human silhouette showing host immune response pathways

The Science

Decoding the Immune System

See how the human body's genetically determined responses to whole categories of stressors enables diagnosticians to develop faster, more accurate diagnoses.

Learn More View Our Evidence

Why HR-B/V?*

Innovative Diagnostics Lead the Way

We are harnessing the potential of Host Response in diagnostics with our advanced molecular testing platforms.

Let's examine what this new frontier means for providers and patients as we tackle, with data, the inappropriate use of antibiotics.

Reduced Unnecessary Use of Antibiotics

Our test aspires to reduce antibiotic overuse and prevent antimicrobial resistance by helping healthcare providers distinguish accurately between bacterial and viral infections.

Rapid Results

Providers can make informed treatment decisions quickly and with confidence as we aim to deliver results in less than an hour.

Improved Patient Outcomes

Accurate diagnosis of bacterial and viral infections can improve patient outcomes by enabling appropriate treatment to be prescribed sooner.

Accessible Testing

Our highly portable molecular testing platforms enable testing to be performed at the point-of-need or in central labs — bringing advanced diagnostics wherever they're needed most.

Novel Solution

Leveraging machine learning and host biology, our test offers a novel solution for the diagnosis, treatment, and management of infectious diseases — moving beyond traditional pathogen-based diagnostics to open a new frontier in how the body itself responds.

Franklin ISP with mobile app showing Bacterial/Viral result

*Biomeme's HR-B/V Test is currently under development and is not approved/cleared by the FDA.

HR-B/V test results on smartphone next to Franklin ISP device

Featured

Empowering Precision Healthcare with Biomeme's HR-B/V Test

Biomeme pioneers a new era in healthcare with the HR-B/V platform — a rapid host response test that differentiates between bacterial and viral infections based on host gene response signatures, not pathogen detection.

*Biomeme's HR-B/V Test is currently under development and is not approved/cleared by the FDA.

Organizations That Rely on Our Products

Interested in Learning More?

Discover the competitive advantage of our end-to-end molecular testing solutions and how host response can transform diagnostics.